The additivity of substrate fragments in enzyme-ligand binding

Structure

Volumn 6, Issue 7, 1998, Pages 839-848

  Stout, Thomas J ^a,b   Sage, Carleton R ^a,b   Stroud, Robert M ^b  

^a MetaXen   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug design; Modular ligand binding; Substrate fragments; Substrate recognition; X ray crystallography

Indexed keywords

ESCHERICHIA COLI;

EID: 0032527698     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(98)00086-0     Document Type: Article

References (37)

1. Carreras, C.W. & Santi, D.V. (1995). The catalytic mechanism and structure of thymidylate synthase. Annu. Rev. Biochem. 64, 721-762.
2. Hardy, LW., et al., & Stroud, R.M. (1987). Atomic structure of thymidylate synthase: target for rational drug design. Science 235, 448-455.
3. Finer-Moore, J.S., Montfort, W.R. & Stroud, R.M. (1990). Pairwise specificity and sequential binding in enzyme catalysis: thymidylate synthase. Biochemistry 29, 6977-6986.
4. Kamb, A., Finer-Moore, J.S. & Stroud, R.M. (1992). Cofactor triggers the conformational change in thymidylate synthase: implications for an ordered binding mechanism. Biochemistry 31, 12876-12884.
5. Finer-Moore, J., et al., & Stroud, R.M. (1993). Refined structures of substrate-bound and phosphate-bound thymidylate synthase from Lactobacillus casei. J. Mol. Biol. 232, 1101-1116.
6. Stroud, R.M. & Finer-Moore, J.S. (1993). Stereochemistry of a multistep/bipartite methyl transfer reaction: thymidylate synthase. FASEB J. 7, 671-677.
7. Perry, K.M., et al., & Stroud, R.M. (1990). Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases. Proteins 8, 315-333.
8. Hartman, K.-R. & Heidelberger, C. (1958). Studies on fluorinated pyrimidines: XIII. Inhibition of thymidylate synthase. J. Biol. Chem. 236, 3006-3013.
9. Heidelberger, C. (1965). Fluorinated pyrimidines. Prog. Nucleic Acid Res. Mol. Biol. 4, 1-50.
10. Montfort, W.R., et al., & Stroud, R.M. (1990). Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate. Biochemistry 29, 6964-6977. Erratum. (1990). Biochemistry 29, 10864.
11. Carreras, C.W., Naber, N., Cooke, R. & Santi, D.V. (1994). A C-terminal conformational equilibrium in thymidylate synthase observed by electron paramagnetic resonance spectroscopy. Biochemistry 33, 2071-2077.
12. Sage, C.R., Rutenber, E.E., Stout, T.J. & Stroud, R.M. (1996). An essential role for water in an enzyme reaction mechanism: the crystal structure of the thymidylate synthase mutant E580. Biochemistry 35, 16270-16281.
13. Westerhof, G.R., et al., & Pinedo, H. M. (1995). Carrier-and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity. Mol. Pharmacol. 48, 459-471.
14. Westerhof, G.R., et al., & Schornagel, J.H. (1991). Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Cancer Res. 51, 5507-5513.
15. 10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse. Cancer Treat. Rep. 70, 971-979.
16. Jansen, G., et al., & Jackman, A.L. (1990). Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors. Cancer Res. 50, 7544-7548.
17. Jackson, R.C., Jackman, A.L. & Calvert, A.H. (1983). Biochemical effects of a quinazoline inhibitor of thymidylate synthase, CB371 7, on human lymphoblastoid cells. Biochem. Pharmacol. 32, 3783-3790.
18. 10-propargyl-5,8-dideazafolic acid (CB3717). Cancer Chemother. Pharmacol. 14, 265-271.
19. Duch, D.S., et al., & Wilson, H.R. (1993). Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase. Cancer Res. 53, 810-818.
20. Hanlon, M.H. & Ferone, R. (1996). In vitro uptake, anabolism, and cellular retention of 1843U89 and other benzoquinazoline inhibitors of thymidylate synthase. Cancer Res. 56, 3301-3306.
21. Gibson, W., et al., & Jackman, A.L. (1993). The measurement of polyglutamate metabolites of the thymidylate synthase inhibitor, ICI D1694, in mouse and human cultured cells. Biochem. Pharmacol. 45, 863-869.
22. Jodrell, D.I., Newell, D.R., Gibson, W., Hughes, L.R. & Calvert, A.H. (1991). The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and rats. Cancer Chemother. Pharmacol. 28, 331-338.
23. Ward, W.H., Kimbell, R. & Jackman, A.L. (1992). Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase. Biochem. Pharmacol. 43, 2029-2031.
24. Kleywegt, G.J. & Jones, T.A. (1994). A super position ESRCCP4 Newslett. 31, 9-14.
25. Pogolotti, A.L., Jr., Danenberg, P.V. & Santi, D.V. (1986). Kinetics and mechanism of interaction of 10-propargyl-5,8-dideazafolate with thymidylate synthase. J. Med. Chem. 29, 478-482.
26. Santi, D.V. & Danenberg, P.V. (1 984). In Folates and Pterins, Vol. I. (Blakely, R.L. & Bencovic, S.J., eds), pp. 345-399, Wiley, New York.
27. Dev, I.K., Yates, B.B., Hanlon, M., Ferone, R. & Dallas, W.S. (1992). Mode of binding of the folate analogs PDDF and BW1843U89 to human thymidylate synthase. Abstract from the Meeting of the American Association for Cancer Research, 2429.
28. Lockshin, A. & Danenberg, P.V. (1981). Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase. Biochem. Pharmacol. 30, 247-257.
29. Reyes, P. & Heidelberger, C. (1965). Fluorinated pyrimidines. XXVI. Mammalian thymidylate synthetase: its mechanism of action and inhibition by fluorinated nucleotides. Mol. Pharmacol. 1, 14-30.
30. Liu, L. & Santi, D.V. (1992). Mutation of asparagine 229 to aspartate in thymidylate synthase converts the enzyme to a deoxycytidylate methylase. Biochemistry 31, 5100-5104.
31. Agarwalla, S., et al., & Santi, D.V. (1997). A Novel dCMP methylase by engineering thymidylate synthase. Biochemistry 36, 15909-1 5917.
32. Otwinowski, Z. (1993). Oscillation data reduction program. In Proceedings of the CCP4 Study Weekend: 'Data Collection and Processing'. (Sawyer, L., Isaacs, N. & Bailey, S., eds), SERC Daresbury Laboratory, UK.
33. Brünger, A.T. (1992). X-PLOR Version 3.1. A System for X-ray Crystallography and NMR. Yale University Press, New Haven, CT.
34. Sack, J.S. (1988). CHAIN - a crystallographic modelling program. J. Mol. Graph. 6, 244-245.
35. Kleywegt, G.J. & Jones, T.A. (1995). Where freedom is given, liberties are taken. Structure 3, 535-540.
36. Kleywegt, G.J. & Jones, T.A. (1996). Phi/Psi-chology: Ramachandran revisited. Structure 4, 1395-1400.
37. Laskowski, R.A., MacArthur, M.W., Moss, D.S. & Thornton, J.M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283-291.